The global extracorporeal CO2 removal devices market size is expected to be worth around US$ 121.64 million by 2030, according to a new report by Vision Research Reports.
The global extracorporeal CO2 removal devices market size was valued at US$ 84.80 million in 2020 and is anticipated to grow at a CAGR of 7.3% during forecast period 2021 to 2030.
Get Sample Copy of This Report (Including TOC, List of Tables & Figures, and Chart)@ https://www.visionresearchreports.com/report/sample/38682
Extracorporeal CO2 Removal Devices Market (By Product: Extracorporeal CO2 Machines, Disposables, Others; By Application: Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD), Bridge to Lung Transplant, Others; By Access: Venovenous, Arteriovenous; By End-use: Hospitals, Ambulatory Surgical Centers, Clinics, Others) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030
|Market Size||USD 121.64 million by 2030|
|Growth Rate||CAGR of 7.3% From 2021 to 2030|
|Forecast Period||2021 to 2030|
|Segments Covered||Product, Application, Access, End use|
|Regional Scope||North America, Europe, Asia Pacific, Latin America, Middle East & Africa|
|Companies Mentioned||Medtronic; Getinge AB; Xenios AG; Alung Technologies; ESTOR SpA; Medica SpA; Aferectica Srl|
Technological improvements have changed extracorporeal techniques for CO2 removal in a promising manner to avoid respiratory failure, worsening respiratory acidosis, and to possibly shorten or prevent the duration of invasive mechanical ventilation in patients with exacerbation of asthma and Chronic Obstructive Pulmonary Disease (COPD).
An increasing number of regulatory product approvals for several extracorporeal removal devices during the COVID-19 pandemic helped various market players to increase their product sales. For instance, in April 2020, Alung Technologies received Emergency Use Authorization (EUA) from the U.S. FDA for Hemolung Respiratory Assist System (RAS) for the treatment of COVID-19.
By Product Analysis
The extracorporeal CO2 machines segment accounted for the largest revenue share of 52.3% in 2020. Technical simplification has caused the development and potential applications of extracorporeal CO2 extraction devices to progress rapidly, avoiding nearly some of the initial problems associated with ECMO.
The disposables segment is expected to grow at a significant CAGR of 4.87% over the forecast period. Disposables are used per procedures per patient basis in extracorporeal CO2 removal therapy. High consumption and demand for consumables in such procedures are predicted to augment the segment growth.
By Access Analysis
The venovenous segment accounted for the highest revenue share of 65.30% in 2020. In venovenous access, the blood is drawn from the central vein through a drainage cannula using a roller or centrifugal pump to produce flow across the gas exchange membrane. In recent years, a new generation of extracorporeal CO2 removal devices has been developed.
The arteriovenous segment is estimated to register the fastest CAGR over the forecast years. With arteriovenous extracorporeal CO2 removal devices, the blood flows from the femoral artery with the help of a gas exchanger and returns into the contralateral femoral vein.
By End-use Analysis
The hospitals segment captured the largest revenue share of over 47.36% in 2020. An increasing number of hospital admissions, especially the patients suffering from ARDS due to the recent outbreak of COVID-19, is predicted to boost the segment growth.Rising cases of COPD and ARDS are also anticipated to fuel the product demand in hospitals.
The Ambulatory Surgical Centers (ASCs) segment is projected to register significant CAGR from 2021 to 2030. This growth can be accredited to the rising cases of acute respiratory failure, especially in rural areas that have limited access to healthcare services.
By Application Analysis
The bridge to lung transplant segment accounted for the largest revenue share of more than 40% in 2020. Patients waiting for lung transplantation that develop life-threatening hypercarbia may benefit from extracorporeal CO2 removal devices by using them as a bridge to transplantation.
The rising focus of manufacturers, such as Alung Technologies and Xenios AG, on developing extracorporeal CO2 removal devices for bridge to lung transplantation is anticipated to spur the market growth during the forecast period.
By Regional Analysis
Asia Pacific is anticipated to register the largest CAGR of 8.24% during the forecast period. The presence of a large patient pool, rising awareness regarding acute respiratory failure, increasing government healthcare expenditure in developing countries, such as India and Japan, are predicted to accelerate the regional market growth.
A huge population base with low per capita income in the region leads to high demand for affordable treatment options. Thus, multinational companies are looking forward to investing in developing countries, such as China, anticipating regional market growth.
Early adoption of novel technologies and a large patient pool of ARDS and COPD are also anticipated to accelerate the regional market growth. In addition, increasing cases of chronic respiratory diseases are anticipated to create demand for extracorporeal CO2 removal devices.
The market in Europe is expected to expand at the second-fastest CAGR of over 7% during the forecast period. Increasing demand for healthcare devices coupled with the rising prevalence of chronic diseases, such as respiratory failure, is expected to drive the regional market.
- Getinge AB
- Xenios AG
- Alung Technologies
- ESTOR SpA
- Medica SpA
- Aferectica Srl
- Extracorporeal CO2 Machines
- Acute Respiratory Distress Syndrome (ARDS)
- Chronic Obstructive Pulmonary Disease (COPD)
- Bridge to Lung Transplant
- Ambulatory Surgical Centers
- North America
- Asia Pacific
- South Korea
- Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- North America
The study objectives of this report are:
- To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
- Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- To define, describe and forecast the market by type, application and region.
- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
- To identify significant trends and factors driving or inhibiting the market growth.
- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
- To strategically profile the key players and comprehensively analyze their growth strategies.
Buy This Premium Research Report, click here@ https://www.visionresearchreports.com/report/cart/38682 or call: +1 9197 992 333